TrialESMO open2025

Safety and efficacy of tiragolumab, atezolizumab and chemotherapy for early-stage or PD-L1-positive advanced triple-negative breast cancer: a phase Ib study.

S Kuemmel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.